ITGA9 and neuroblastoma: Thus, we can hypothesize the possibility that, in our RMS, NB and BC animal experimental models, ITGA9 impairment would be able to hinder cell cycle re-entry once cells reached the niche tissue, thereby pointing to an inhibition of cell reactivation at this stage.